Erythromycin-nonsusceptible Streptococcus pneumoniae in children, 1999-2001

Emerg Infect Dis. 2005 Jun;11(6):969-72. doi: 10.3201/eid1106.050119.

Abstract

After increasing from 1995 to 1999, invasive erythromycin-nonsusceptible Streptococcus pneumoniae rates per 100,000 decreased 53.6% in children from Baltimore, Maryland (US), from 1999 to 2001, which was partially attributed to strains related to the mefE-carrying England14-9 clone. The decline in infection rates was likely due to the pneumococcal 7-valent conjugate vaccine.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial* / genetics
  • Erythromycin / pharmacology*
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Maryland / epidemiology
  • Membrane Proteins / genetics
  • Microbial Sensitivity Tests
  • Pneumococcal Infections / epidemiology*
  • Pneumococcal Infections / microbiology
  • Streptococcus pneumoniae / drug effects*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • MefE protein, Streptococcus pneumoniae
  • Membrane Proteins
  • Erythromycin